Titan Medical Inc.
TMDIF · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Market Cap | $0 | $2 | $2 | $3 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $2 | $2 | $3 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | -100% | -5.4% | – |
| Gross Profit | $0 | -$0 | $0 | $0 |
| % Margin | 98.9% | – | 100% | 100% |
| EBITDA | $0 | -$0 | -$0 | -$0 |
| % Margin | 41.9% | – | -69.6% | -108.5% |
| Net Income | $0 | -$0 | -$0 | -$0 |
| % Margin | 38.7% | – | -73.9% | -120.9% |
| EPS Diluted | 0.061 | -0.37 | -0.14 | -0.38 |
| % Growth | 116.4% | -164.3% | 63.2% | – |
| Operating Cash Flow | $0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | -$0 | -$0 | -$0 |